Resverlogix (FRA:RFS) Shiller PE Ratio: (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:RFS Resverlogix Corp FRA:RFS
17 GF Score
Price €0.05
! 5 Warning Signs
View Full Analysis

What is Resverlogix Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Resverlogix  (FRA:RFS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Resverlogix Shiller PE Ratio Related Terms


Resverlogix Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Resverlogix's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Resverlogix Shiller PE Ratio Chart

Resverlogix Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Resverlogix Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:RFS vs VRTX, REGN, RVMD: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Resverlogix's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Resverlogix Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Resverlogix's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Resverlogix's Shiller PE Ratio falls into.


FRA:RFS
17GF Score
Resverlogix Corp FRA:RFS
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Resverlogix Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Resverlogix's E10 for the quarter that ended in Mar. 2026 is calculated as:

For example, Resverlogix's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.009/132.2623*132.2623
=-0.009

Current CPI (Mar. 2026) = 132.2623.

Resverlogix Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201604 -0.088 101.370 -0.115
201607 -0.054 101.844 -0.070
201610 -0.127 102.002 -0.165
201701 -0.113 102.318 -0.146
201704 -0.103 103.029 -0.132
201707 -0.121 103.029 -0.155
201710 -0.085 103.424 -0.109
201801 -0.123 104.056 -0.156
201804 -0.016 105.320 -0.020
201807 -0.240 106.110 -0.299
201810 -0.183 105.952 -0.228
201901 -0.061 105.557 -0.076
201904 -0.285 107.453 -0.351
201907 0.018 108.243 0.022
201910 0.416 107.927 0.510
202001 0.018 108.085 0.022
202004 0.037 107.216 0.046
202007 -0.026 108.401 -0.032
202010 -0.017 108.638 -0.021
202103 0.000 110.298 0.000
202106 -0.008 111.720 -0.009
202109 -0.017 112.905 -0.020
202112 -0.062 113.774 -0.072
202203 -0.009 117.646 -0.010
202206 -0.002 120.806 -0.002
202209 -0.010 120.648 -0.011
202212 0.009 120.964 0.010
202303 -0.019 122.702 -0.020
202306 -0.009 124.203 -0.010
202309 -0.019 125.230 -0.020
202312 -0.009 125.072 -0.010
202403 0.000 126.258 0.000
202406 -0.019 127.522 -0.020
202409 -0.018 127.285 -0.019
202412 0.000 127.364 0.000
202503 -0.018 129.181 -0.018
202506 -0.009 129.892 -0.009
202509 0.000 130.287 0.000
202512 0.000 130.366 0.000
202603 -0.009 132.262 -0.009

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Resverlogix Business Description

Other Exchanges RVXCF:USARVX:Canada
Address 4820 Richard Road SW, Suite 300, Calgary, AB, CAN, T3E 6L1
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra-terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease, including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.
17GF Score

Get the complete analysis for FRA:RFS

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.05
Price